Postdoc start-up grant: Modelling short QT syndrome using human-induced pluripotent stem cell derived cardiomyocytes: Drug screening and carnitine as a therapeutic target
| Institution | Ruprecht-Karls-Universität Heidelberg |
|---|---|
| Project leader | Ibrahim El-Battrawy |
| Site | Heidelberg/Mannheim |
| Project type | Exzellenzprogramm |
| Funding | € 56.061,97 |
| Begin | 01.02.2018 |
| End | 31.01.2019 |
Förderkennzeichen
81X3500204
Projektnummer
971